Semiconductors
Compare Stocks
5 / 10Stock Comparison
QUIK vs AEHR vs SIFY vs AMBA vs MRAM
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Telecommunications Services
Semiconductors
Semiconductors
QUIK vs AEHR vs SIFY vs AMBA vs MRAM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Telecommunications Services | Semiconductors | Semiconductors |
| Market Cap | $294M | $2.79B | $1.15B | $3.20B | $502M |
| Revenue (TTM) | $16M | $49M | $41.45B | $374M | $57M |
| Net Income (TTM) | $-9M | $-11M | $-1.50B | $-80M | $284K |
| Gross Margin | 36.7% | 30.2% | 34.2% | 59.8% | 51.5% |
| Operating Margin | -55.0% | -27.8% | 5.2% | -23.6% | -12.8% |
| Forward P/E | — | — | — | 95.4x | 860.4x |
| Total Debt | $22M | $11M | $39.51B | $5M | $3M |
| Cash & Equiv. | $22M | $25M | $5.00B | $145M | $44M |
QUIK vs AEHR vs SIFY vs AMBA vs MRAM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| QuickLogic Corporat… (QUIK) | 100 | 356.9 | +256.9% |
| Aehr Test Systems (AEHR) | 100 | 5530.9 | +5430.9% |
| Sify Technologies L… (SIFY) | 100 | 284.6 | +184.6% |
| Ambarella, Inc. (AMBA) | 100 | 130.9 | +30.9% |
| Everspin Technologi… (MRAM) | 100 | 365.2 | +265.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: QUIK vs AEHR vs SIFY vs AMBA vs MRAM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, QUIK doesn't own a clear edge in any measured category.
AEHR is the clearest fit if your priority is long-term compounding.
- 70.3% 10Y total return vs MRAM's 168.2%
- +9.9% vs AMBA's +45.5%
SIFY has the current edge in this matchup, primarily because of its strength in income & stability and defensive.
- Dividend streak 0 yrs, beta 1.33, yield 0.0%
- Beta 1.33, yield 0.0%, current ratio 0.96x
- Beta 1.33 vs AEHR's 4.77
- 0.0% yield; the other 4 pay no meaningful dividend
AMBA is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 25.8%, EPS growth 33.2%, 3Y rev CAGR -5.0%
- Lower volatility, beta 2.53, Low D/E 0.9%, current ratio 2.65x
- 25.8% revenue growth vs AEHR's -20.2%
- Lower P/E (95.4x vs 860.4x)
MRAM ranks third and is worth considering specifically for quality and efficiency.
- 0.5% margin vs QUIK's -58.3%
- 0.3% ROA vs QUIK's -18.6%, ROIC -18.4% vs -13.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 25.8% revenue growth vs AEHR's -20.2% | |
| Value | Lower P/E (95.4x vs 860.4x) | |
| Quality / Margins | 0.5% margin vs QUIK's -58.3% | |
| Stability / Safety | Beta 1.33 vs AEHR's 4.77 | |
| Dividends | 0.0% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +9.9% vs AMBA's +45.5% | |
| Efficiency (ROA) | 0.3% ROA vs QUIK's -18.6%, ROIC -18.4% vs -13.0% |
QUIK vs AEHR vs SIFY vs AMBA vs MRAM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
QUIK vs AEHR vs SIFY vs AMBA vs MRAM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMBA leads in 1 of 6 categories
AEHR leads 1 • QUIK leads 0 • SIFY leads 0 • MRAM leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AMBA leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SIFY is the larger business by revenue, generating $41.4B annually — 2632.2x QUIK's $16M. MRAM is the more profitable business, keeping 0.5% of every revenue dollar as net income compared to QUIK's -58.3%. On growth, AMBA holds the edge at +31.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $16M | $49M | $41.4B | $374M | $57M |
| EBITDAEarnings before interest/tax | -$4M | -$10M | $8.1B | -$72M | -$4M |
| Net IncomeAfter-tax profit | -$9M | -$11M | -$1.5B | -$80M | $284,000 |
| Free Cash FlowCash after capex | -$7M | -$14M | $0 | $76M | -$1M |
| Gross MarginGross profit ÷ Revenue | +36.7% | +30.2% | +34.2% | +59.8% | +51.5% |
| Operating MarginEBIT ÷ Revenue | -55.0% | -27.8% | +5.2% | -23.6% | -12.8% |
| Net MarginNet income ÷ Revenue | -58.3% | -22.7% | -3.6% | -21.3% | +0.5% |
| FCF MarginFCF ÷ Revenue | -46.3% | -28.1% | -9.2% | +20.3% | -2.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -52.5% | -26.5% | +2.5% | +31.2% | +13.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -71.4% | -2.2% | -3.7% | +39.7% | +74.4% |
Valuation Metrics
Evenly matched — SIFY and AMBA each lead in 2 of 5 comparable metrics.
Valuation Metrics
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $294M | $2.8B | $1.1B | $3.2B | $502M |
| Enterprise ValueMkt cap + debt − cash | $294M | $2.8B | $1.5B | $3.1B | $461M |
| Trailing P/EPrice ÷ TTM EPS | -67.54x | -702.00x | -119.57x | -26.15x | -827.31x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 95.39x | 860.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 18.19x | — | — |
| Price / SalesMarket cap ÷ Revenue | 14.64x | 47.39x | 2.73x | 11.22x | 9.09x |
| Price / BookPrice ÷ Book value/share | 10.24x | 21.97x | 4.65x | 5.46x | 7.04x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 136.31x | 160.68x |
Profitability & Efficiency
Evenly matched — SIFY and AMBA and MRAM each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
MRAM delivers a 0.4% return on equity — every $100 of shareholder capital generates $0 in annual profit, vs $-35 for QUIK. AMBA carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to SIFY's 1.96x. On the Piotroski fundamental quality scale (0–9), AMBA scores 6/9 vs AEHR's 1/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -35.4% | -8.5% | -7.7% | -13.5% | +0.4% |
| ROA (TTM)Return on assets | -18.6% | -7.5% | -1.8% | -10.6% | +0.3% |
| ROICReturn on invested capital | -13.0% | -3.0% | +3.3% | -22.5% | -18.4% |
| ROCEReturn on capital employed | -15.4% | -3.2% | +4.4% | -22.2% | -9.4% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 1 | 3 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.88x | 0.09x | 1.96x | 0.01x | 0.05x |
| Net DebtTotal debt minus cash | -$19,000 | -$14M | $34.5B | -$139M | -$41M |
| Cash & Equiv.Liquid assets | $22M | $25M | $5.0B | $145M | $44M |
| Total DebtShort + long-term debt | $22M | $11M | $39.5B | $5M | $3M |
| Interest CoverageEBIT ÷ Interest expense | -21.26x | — | 0.82x | — | — |
Total Returns (Dividends Reinvested)
AEHR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AEHR five years ago would be worth $398,515 today (with dividends reinvested), compared to $8,015 for AMBA. Over the past 12 months, AEHR leads with a +991.6% total return vs AMBA's +45.5%. The 3-year compound annual growth rate (CAGR) favors AEHR at 50.7% vs AMBA's 3.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +179.6% | +311.8% | +29.2% | -1.2% | +113.8% |
| 1-Year ReturnPast 12 months | +210.2% | +991.6% | +264.2% | +45.5% | +266.4% |
| 3-Year ReturnCumulative with dividends | +217.0% | +242.3% | +113.4% | +10.8% | +195.5% |
| 5-Year ReturnCumulative with dividends | +182.3% | +3885.1% | -12.1% | -19.8% | +312.1% |
| 10-Year ReturnCumulative with dividends | +25.4% | +7029.7% | +141.0% | +94.1% | +168.2% |
| CAGR (3Y)Annualised 3-year return | +46.9% | +50.7% | +28.8% | +3.5% | +43.5% |
Risk & Volatility
Evenly matched — SIFY and MRAM each lead in 1 of 2 comparable metrics.
Risk & Volatility
SIFY is the less volatile stock with a 1.33 beta — it tends to amplify market swings less than AEHR's 4.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MRAM currently trades 94.8% from its 52-week high vs AMBA's 76.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.36x | 4.77x | 1.33x | 2.53x | 2.85x |
| 52-Week HighHighest price in past year | $18.98 | $102.48 | $17.85 | $96.69 | $22.69 |
| 52-Week LowLowest price in past year | $4.80 | $8.06 | $4.15 | $48.30 | $5.49 |
| % of 52W HighCurrent price vs 52-week peak | +92.5% | +89.1% | +89.0% | +76.8% | +94.8% |
| RSI (14)Momentum oscillator 0–100 | 77.7 | 67.6 | 56.7 | 78.9 | 75.3 |
| Avg Volume (50D)Average daily shares traded | 344K | 3.0M | 56K | 875K | 1.0M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: QUIK as "Buy", AEHR as "Hold", SIFY as "Buy", AMBA as "Buy", MRAM as "Buy". Consensus price targets imply 32.4% upside for AMBA (target: $98) vs -58.2% for MRAM (target: $9).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $10.00 | $62.00 | — | $98.33 | $9.00 |
| # AnalystsCovering analysts | 4 | 3 | 1 | 36 | 5 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.0% | — | — |
| Dividend StreakConsecutive years of raises | — | — | 0 | — | — |
| Dividend / ShareAnnual DPS | — | — | $0.36 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.0% | 0.0% | 0.0% | 0.0% |
AMBA leads in 1 of 6 categories (Income & Cash Flow). AEHR leads in 1 (Total Returns). 3 tied.
QUIK vs AEHR vs SIFY vs AMBA vs MRAM: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is QUIK or AEHR or SIFY or AMBA or MRAM a better buy right now?
For growth investors, Ambarella, Inc.
(AMBA) is the stronger pick with 25. 8% revenue growth year-over-year, versus -5. 1% for QuickLogic Corporation (QUIK). Analysts rate QuickLogic Corporation (QUIK) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — QUIK or AEHR or SIFY or AMBA or MRAM?
Over the past 5 years, Aehr Test Systems (AEHR) delivered a total return of +38.
9%, compared to -19. 8% for Ambarella, Inc. (AMBA). Over 10 years, the gap is even starker: AEHR returned +70. 3% versus QUIK's +25. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — QUIK or AEHR or SIFY or AMBA or MRAM?
By beta (market sensitivity over 5 years), Sify Technologies Limited (SIFY) is the lower-risk stock at 1.
33β versus Aehr Test Systems's 4. 77β — meaning AEHR is approximately 260% more volatile than SIFY relative to the S&P 500. On balance sheet safety, Ambarella, Inc. (AMBA) carries a lower debt/equity ratio of 1% versus 196% for Sify Technologies Limited — giving it more financial flexibility in a downturn.
04Which is growing faster — QUIK or AEHR or SIFY or AMBA or MRAM?
By revenue growth (latest reported year), Ambarella, Inc.
(AMBA) is pulling ahead at 25. 8% versus -5. 1% for QuickLogic Corporation (QUIK). On earnings-per-share growth, the picture is similar: Ambarella, Inc. grew EPS 33. 2% year-over-year, compared to -1233. 3% for QuickLogic Corporation. Over a 3-year CAGR, QUIK leads at 16. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — QUIK or AEHR or SIFY or AMBA or MRAM?
Everspin Technologies, Inc.
(MRAM) is the more profitable company, earning -1. 1% net margin versus -41. 1% for Ambarella, Inc. — meaning it keeps -1. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIFY leads at 5. 7% versus -44. 4% for AMBA. At the gross margin level — before operating expenses — AMBA leads at 60. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is QUIK or AEHR or SIFY or AMBA or MRAM more undervalued right now?
On forward earnings alone, Ambarella, Inc.
(AMBA) trades at 95. 4x forward P/E versus 860. 4x for Everspin Technologies, Inc. — 765. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMBA: 32. 4% to $98. 33.
07Which pays a better dividend — QUIK or AEHR or SIFY or AMBA or MRAM?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is QUIK or AEHR or SIFY or AMBA or MRAM better for a retirement portfolio?
For long-horizon retirement investors, Sify Technologies Limited (SIFY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+141.
0% 10Y return). QuickLogic Corporation (QUIK) carries a higher beta of 2. 36 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SIFY: +141. 0%, QUIK: +25. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between QUIK and AEHR and SIFY and AMBA and MRAM?
These companies operate in different sectors (QUIK (Technology) and AEHR (Technology) and SIFY (Communication Services) and AMBA (Technology) and MRAM (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: QUIK is a small-cap quality compounder stock; AEHR is a small-cap quality compounder stock; SIFY is a small-cap quality compounder stock; AMBA is a small-cap high-growth stock; MRAM is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.